et al., The Journal of Clinical Endocrinology & Metabolism 2
In this regard, when prescribing GLP-1 therapy, clinicians tend to recommend it in combination with lifestyle modifications
Wegovy is approved by the FDA for several conditions: Weight loss and maintenance in adults and children 12 years and older who have obesity, and in adults who are overweight with at least one related health issue such as high blood pressure or high cholesterol
While it is found throughout the body, it is most concentrated in the liver, which serves as our primary filtration and detoxification center
However, injection-based use carries important concerns, including sterility, contamination risk, uncertain dosing, and lack of regulatory oversight